Tue.Jun 17, 2025

article thumbnail

STAT+: Doctors lose Medicare pay bump in Senate version of tax bill

STAT

The Medicare pay bump for doctors that was part of the House version of Republicans’ tax bill was dropped in the Senate’s version, released Monday evening.  The provision, which would boost doctors’ payment for treating Medicare patients by tying it to inflation, has long been a top priority for physician groups.  For years, doctors have contended with pay cuts from Medicare, which physician groups say have led to the consolidation and closure of medical practices.

255
255
article thumbnail

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

The Guardian - Pharmaceutical Industry

As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’ A drug with the potential to “end the HIV pandemic” will launch in the US this week – as a new study reveals it could be sold for 1,000 times less than its possible price tag. Lenacapavir, given as a twice-yearly injection, can prevent someone from being infected with HIV, according to clinical trial results.

111
111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sheffield scientists and AstraZeneca develop new machine learning model for inverse protein folding

Express Pharma

In a study published in Nature Machine Intelligence , researchers from the University of Sheffield, in collaboration with AstraZeneca and the University of Southampton, have developed a machine learning framework that demonstrates improved accuracy in inverse protein folding compared to existing methods. Inverse protein folding involves identifying amino acid sequences that form a desired 3D protein structure.

article thumbnail

AI-powered orchestration: Bringing the benefits to personalized therapy

Pharmaceutical Technology

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient safety and regulatory compliance. AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Genentech's Bittenbender named board chair at BIO

pharmaphorum

Genentech's Fritz Bittenbender becomes chair of the Biotechnology Innovation Organization at a challenging time for the sector.

90
article thumbnail

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs FDA approves UroGen’s Zusduri to treat recurrent bladder cancer by Emily Kimber | 17th Jun 2025 | News Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food and Drug Administration (FDA) has approved UroGen Pharma’s Zusduri (mitomycin intravesical solutio

130
130

More Trending

article thumbnail

Changing the PAP Model

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

IDMA to host IDMA CARES – Creating accountable, respectful, empowered & safe workplaces for the Indian pharma sector

Express Pharma

Future-proofing your business in a diverse, multi-gen, high-tech, new-priority-focussed world is now a ‘MUST-DO’. Join us as we share simple, effective and sustainable ways to leverage new-age business strategies that sync with our current talent, consumers and emerging markets. Why Attend? We will have pharma promoters, C-suites, next-gen leaders co-create: A first-mover insight based on the Indian Government’s stance and strategy on ESG and PoSH: – Dr Mansukh Mandaviya, Hon’ble Minist

59
article thumbnail

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from March 2025. Three’s still company in the world of pharmacy benefit managers.

article thumbnail

23andMe fined £2.31m over UK users' genetic data breach

pharmaphorum

Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data

75
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

European pharma needs scalable models to succeed in US

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Bolstering Health Technology Assessment With the Help of AI

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

New strategy for the treatment of severe childhood cancer

World Pharma News

Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer. By combining two antioxidant enzyme inhibitors, they have converted cancer cells in mice into healthy nerve cells. The study is published in the journal Proceedings of the National Academy of Sciences (PNAS).

81
article thumbnail

Averoa secures EC authorisation for oral CKD treatment

Pharmaceutical Technology

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney disease (CKD).

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Caris swells its planned IPO, seeking $5.7bn valuation

pharmaphorum

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Wh

article thumbnail

NextCure and Simcere partner to develop SIM0505 for solid tumours

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Is Lilly about to swoop on Verve Therapeutics?

pharmaphorum

Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics

59
article thumbnail

Why AI Is Hitting Infrastructure Limits and What To Do Next

Pharma and Life Sciences Blog

Why AI Is Hitting Infrastructure Limits and What To Do Next priyanka.katke… Tue, 06/17/2025 - 19:03 AI is only as strong as the infrastructure behind it. But the electric grids are strained. Data center parts are running low. Construction is facing delays. Infrastructure has become AI’s Achilles’ heel — the single point of failure with the power to stall progress.

52
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

FDA grants fast-track status to SolasCure’s gel for calciphylaxis ulcers

Pharmaceutical Business Review

This status signifies the potential of the gel to broaden its therapeutic applications in chronic wound healing, accelerating its availability to patients. SolasCure noted that this hydrogel releases recombinant enzyme, Tarumase, that targets collagen, fibrin, and elastin in wounds, promoting healing via debridement and wound bed preparation. At present, the gel is in Phase II trials to treat venous leg ulcers and has shown a pain-free application and safety profile.

article thumbnail

Pharma Pulse 6/17/25: How AI and Regulation are Reshaping the Future of Drug Safety; A Reflection on Our Path Forward

Pharmaceutical Commerce

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

52
article thumbnail

Smartphone app for treating depression launches in UK

Pharmafile

Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The smartphone app is designed to be used alongside existing treatments and is currently being deployed within select NHS Trusts, with broader uptake anticipated over the coming year. Rejoyn delivers a six-week cognitive training programme that […] The post Smartphone app for treating depression launches in UK appeared first on Pharmafile.

59
article thumbnail

European biotech ecosystem takes aim at changing the funding narrative

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Biotium launches new DNA gel analysis technology

Pharmafile

Biotium has announced the launch of its new glo-plate white photoactivation device, a compact LED-powered light box designed to support DNA gel analysis in educational and academic labs. The glo-plate white provides bright, uniform white LED illumination, allowing clear visualisation of DNA bands stained with Biotium’s DNAzure blue nucleic acid gel stain.

59
article thumbnail

Lilly to acquire Verve in $1B bet on gene editing for heart disease

BioPharma Dive

The deal centers around a medicine that could “shift the treatment paradigm for cardiovascular disease,” Lilly said, but also follows a yearslong in decline in Verve’s share price amid skepticism over the need for such a therapy.

75
article thumbnail

Enhancing chromatographic protein purification with light

European Pharmaceutical Review

Researchers have demonstrated a generic affinity (bioaffinity) chromatography method that enables recombinant protein purification via UV light. Use of Excitography (light-controlled single-step protein purification) did not require “competing agents or harsh buffer conditions as is standard in these processes”. It operated “under native buffer conditions in a functional state and, optionally, in a high-throughput fashion”, Mayrhofer et al. explained.

article thumbnail

Update: Rumour confirmed as Lilly buys Verve Therapeutics

pharmaphorum

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Wh

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

‘Little capacity’ to deliver NHS reforms without primary care investment

The Pharmacist

The government has been warned there is ‘little capacity’ to deliver its reforms to the NHS without further investment in primary care, in a joint statement from five national primary care bodies. Community Pharmacy England (CPE), the General Practitioner’s Committee England (GPCE) and others have joined forces following last week’s spending review to reiterate their […] The post ‘Little capacity’ to deliver NHS reforms without primary care investment appeared first on The Pharmacist.

article thumbnail

Pharmacy School Costs in 2025

UWorld | RxPrep

Empower your pharmacy school decision-making with a comprehensive breakdown of tuition costs, financial aid options, and smart ways to save throughout your journey.

40
article thumbnail

Astoriom appoints Brittany Jackson as CFO

Pharmafile

Astoriom, a R&D sample stability and biorepository storage company, has appointed Brittany Jackson as chief financial officer (CFO). Jackson will work alongside the team to support the company’s financial and strategic initiatives and continue strengthening the organisation’s growth in global markets. Jackson brings extensive experience in financial leadership across biotech, manufacturing, education, hospitality and professional […] The post Astoriom appoints Brittany Jackson as

article thumbnail

Ex-ACIP panel warns of ‘critically weakened’ US immunisation programme

Pharmaceutical Technology

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.